A U.S. Food and Drug Administration advisory panel agreed that the agency had erred when it said the chemical widely used in baby bottles and other plastic packaging for foods and beverages posed no health risks. A panel of toxicology expects said the FDA hadn’t properly assessed the potential health risks posed by the chemical bisphenol A (BPA), which some studies have linked to cancer, diabetes, heart disease and the development delays in children. The toxicologists said the FDA had relied too heavily on studies funded by the chemical industry to make its decision. The panel of toxicologists have been convened by the FDA after the agency ruled that BPA was safe at current exposure levels. An expert stated that “While the dangers of BPA exposure are far from definitely proven, the clear and mounting evidence that BPA is very likely to be harmful should not lead to a statement from the FDA that there is no concern.” He stated that the panel’s recommendation was misleading and gave people false reassurance. The expert is commending the FDA for the re-evaluation. To read the full story, click here.